Sustained Released Bupropion in the Treatment of Trichotillomania: Outpatient Follow-Up Survey

The study explored bupropion SR as an alternative treatment for trichotillomania (TTM) in nine female patients who did not respond to SSRIs. Six out of nine patients showed significant improvement on the Massachusetts General Hospital Hair Pulling Scale after twelve weeks, and the positive effects were sustained at a sixteen-month follow-up. The results suggested that bupropion SR could be a viable treatment option for TTM, but larger, double-blind, placebo-controlled studies were needed to confirm these findings.